Travere Therapeutics Inc (TVTX)

Travere Therapeutics Inc (TVTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $4.9B; returns 1 day -4.5%, 1 week +1.0%, 1 year +77.9%.

Travere Therapeutics Inc. is a biopharmaceutical company dedicated to identifying, developing, and delivering life-changing therapies for people living with rare kidney and metabolic diseases.

Groups TVTX belongs to

• Biotechnology
• Biopharmaceutical
• Rare Diseases
• Nephrology
• Healthcare
• Commercial Stage Biotech
• Metabolic Disorders
• Pharmaceuticals
• Life Sciences
• Clinical Stage

TVTX financial model: income statement, cash flow and balance sheet